Filtros : "Therapeutic Delivery" Removido: "HRAC" Limpar

Filtros



Refine with date range


  • Source: Therapeutic Delivery. Unidade: FOB

    Subjects: ESTOMATITE SOB PRÓTESE, CANDIDÍASE, CLOREXIDINA, ANTIFÚNGICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SCHOEFFEL, Amanda Cristina et al. Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes. Therapeutic Delivery, v. 14, n. 4, p. 295-309, 2023Tradução . . Disponível em: https://doi.org/10.4155/tde-2022-0068. Acesso em: 27 jun. 2025.
    • APA

      Schoeffel, A. C., Morikava, F. S., Urban, A. M., Novatski, A., Moraes, G. S., Matioli, G., et al. (2023). Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes. Therapeutic Delivery, 14( 4), 295-309. doi:10.4155/tde-2022-0068
    • NLM

      Schoeffel AC, Morikava FS, Urban AM, Novatski A, Moraes GS, Matioli G, Ferrari PC, Neppelenbroek KH, Farago PV, Urban VM. Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes [Internet]. Therapeutic Delivery. 2023 ; 14( 4): 295-309.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde-2022-0068
    • Vancouver

      Schoeffel AC, Morikava FS, Urban AM, Novatski A, Moraes GS, Matioli G, Ferrari PC, Neppelenbroek KH, Farago PV, Urban VM. Characterization and antifungal activity of chlorhexidine: β-cyclodextrin inclusion complexes [Internet]. Therapeutic Delivery. 2023 ; 14( 4): 295-309.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde-2022-0068
  • Source: Therapeutic Delivery. Unidade: FMRP

    Subjects: CÉLULAS, DOENÇAS INFECCIOSAS, FUNGOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Thiago Aparecido da. CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial]. Therapeutic Delivery. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.4155/tde-2021-0046. Acesso em: 27 jun. 2025. , 2021
    • APA

      Silva, T. A. da. (2021). CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial]. Therapeutic Delivery. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.4155/tde-2021-0046
    • NLM

      Silva TA da. CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial] [Internet]. Therapeutic Delivery. 2021 ; 12( 9): 627-630.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde-2021-0046
    • Vancouver

      Silva TA da. CAR T Cell-therapy for infectious diseases with emphasis on invasive fungal infections [Editorial] [Internet]. Therapeutic Delivery. 2021 ; 12( 9): 627-630.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde-2021-0046
  • Source: Therapeutic Delivery. Unidade: FCF

    Subjects: NANOPARTÍCULAS, GELATINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARFRAZ, Muhammad et al. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages. Therapeutic Delivery, v. 7, n. 4, p. 213-228, 2016Tradução . . Disponível em: https://doi.org/10.4155/tde-2015-0007. Acesso em: 27 jun. 2025.
    • APA

      Sarfraz, M., Shi, W., Gao, Y., Clas, S. D., Roa, W., & Bou-Chacra, N. A. (2016). Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages. Therapeutic Delivery, 7( 4), 213-228. doi:10.4155/tde-2015-0007
    • NLM

      Sarfraz M, Shi W, Gao Y, Clas SD, Roa W, Bou-Chacra NA. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages [Internet]. Therapeutic Delivery. 2016 ; 7( 4): 213-228.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde-2015-0007
    • Vancouver

      Sarfraz M, Shi W, Gao Y, Clas SD, Roa W, Bou-Chacra NA. Immune response to antituberculosis drug-loaded gelatin and polyisobutyl-cyanoacrylate nanoparticles in macrophages [Internet]. Therapeutic Delivery. 2016 ; 7( 4): 213-228.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde-2015-0007
  • Source: Therapeutic Delivery. Unidades: ICB, FCFRP

    Subjects: FARMACOLOGIA, PELE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOPES, Luciana Biagini e GARCIA, Maria Teresa Junqueira e BENTLEY, Maria Vitoria Lopes Badra. Chemical penetration enhancers. Therapeutic Delivery, v. 6, n. 9, p. 1053-1061, 2015Tradução . . Disponível em: https://doi.org/10.4155/tde.15.61. Acesso em: 27 jun. 2025.
    • APA

      Lopes, L. B., Garcia, M. T. J., & Bentley, M. V. L. B. (2015). Chemical penetration enhancers. Therapeutic Delivery, 6( 9), 1053-1061. doi:10.4155/tde.15.61
    • NLM

      Lopes LB, Garcia MTJ, Bentley MVLB. Chemical penetration enhancers [Internet]. Therapeutic Delivery. 2015 ; 6( 9): 1053-1061.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde.15.61
    • Vancouver

      Lopes LB, Garcia MTJ, Bentley MVLB. Chemical penetration enhancers [Internet]. Therapeutic Delivery. 2015 ; 6( 9): 1053-1061.[citado 2025 jun. 27 ] Available from: https://doi.org/10.4155/tde.15.61

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025